← Back to Clinical Trials
Recruiting NCT03670524

NCT03670524 Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT03670524
Status Recruiting
Phase —
Sponsor University of Louisville
Condition Cardiovascular Diseases
Study Type INTERVENTIONAL
Enrollment 835 participants
Start Date 2018-05-03
Primary Completion 2027-10-01

Eligibility & Interventions

Sex All sexes
Min Age 30 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
Greenness as a therapeutic intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 835 participants in total. It began in 2018-05-03 with a primary completion date of 2027-10-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to examine how the environment and neighborhood characteristics affects the health of the area residents. The study will help determine how changing neighborhood characteristics, such as green space, affect heart health, risk factors for other diseases, sense of well- being or neighborhood cohesion.

Eligibility Criteria

Inclusion Criteria: * 30-70 years of age. * Live within the targeted study location Exclusion Criteria: * Unwilling or unable to provide consent. * HIV/AIDS, active treatment for cancer, active bleeding including wounds. * Body weight less than 100 pounds or BMI\>40. * Prisoners and other vulnerable populations. * Anyone that PI thinks is unsafe to participate in study.

Contact & Investigator

Central Contact

Jackie Research Coordinator, MS

✉ jacqueline.gallagher@louisville.edu

📞 502-852-6167

Principal Investigator

Aruni Bhatnagar, PhD

STUDY DIRECTOR

University of Louisville

Frequently Asked Questions

Who can join the NCT03670524 clinical trial?

This trial is open to participants of all sexes, aged 30 Years or older, up to 70 Years, studying Cardiovascular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT03670524 currently recruiting?

Yes, NCT03670524 is actively recruiting participants. Contact the research team at jacqueline.gallagher@louisville.edu for enrollment information.

Where is the NCT03670524 trial being conducted?

This trial is being conducted at Louisville, United States.

Who is sponsoring the NCT03670524 clinical trial?

NCT03670524 is sponsored by University of Louisville. The principal investigator is Aruni Bhatnagar, PhD at University of Louisville. The trial plans to enroll 835 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology